Conferences Trial results 22 December 2023 A new order in BTK inhibition Imbruvica faces challenges on multiple fronts. Read more
Conferences Trial results 3 November 2023 ASH 2023 preview – small-molecule duels The upcoming ASH conference will feature rival datasets from inhibitors of Menin, KIT, EZH1/2, BTK, BET, BCR/ABL and more. Read more